Gender Male
Alan is the Chief Financial Officer of Generian. As Founder and Principal of the Prestar Group, he brings more than 30 years of experience to his work for life sciences clients ranging from start-ups to publicly traded companies. He has served as CFO and advisor to numerous companies including Karyopharm Therapeutics, Forma Therapeutics, Foundation
Medicine, Marinus Pharmaceuticals, Durata Therapeutics and Repligen. Over the course of his career, he has assisted in raising more than $500 million in development and growth capital for life sciences companies in the private and public financial markets (including IPOs). Alan is a CPA and began his career in public accounting where he served as a Partner with Pricewaterhouse Coopers. He received a Bachelor of Science Degree in Accounting from the Florida State University, Rovetta School of Business.
